Enjoy complimentary customisation on priority with our Enterprise License!
The medical exoskeleton market size is forecast to increase by USD 2.87 billion, at a CAGR of 55.77% between 2023 and 2028. The market experiences significant growth driven by rising incidences of Spinal Cord Injuries (SCIs), expanding utilization of medical exoskeletons in rehabilitation programs, and broader insurance coverage for these advanced devices. Medical exoskeletons, designed to augment mobility and functionality, are witnessing increased adoption across healthcare facilities globally, particularly in rehabilitation centers and hospitals. With a focus on improving patient outcomes and enhancing quality of life, medical exoskeletons are revolutionizing the field of rehabilitation, offering hope and assistance to individuals with mobility impairments. It also includes an in-depth analysis of market trends and analysis, market growth analysis and challenges. Furthermore, the report includes historic market data from 2018-2022.
To learn more about this report, View Report Sample
The market is experiencing significant growth due to the increasing demand for assistive devices that enhance mobility and improve the quality of life for individuals with various medical conditions. These devices, such as the Severe Musculoskeletal Rehabilitation (SMART) exoskeletons and the FDA-regulated ReWalk exoskeletons, are revolutionizing the way rehabilitation and mobility assistance are provided. The application of these advanced technologies in centers like Ekso Bionics and SCIFIT is instrumental in driving the market forward. The use of these exoskeletons in stand-and-transfer and ambulation applications is particularly noteworthy. The adoption of these devices is also influenced by the availability of government and private funding, as well as the growing awareness and acceptance of these technologies among healthcare professionals and patients. The future of the market looks promising, with advancements in technology and increasing demand from various end-users. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing incidences of SCIs are notably driving the market growth. A person gets SCI when the vertebrae, ligaments, spinal discs, or nerves at the end of the spinal canal (cauda equina) are damaged, causing a permanent loss of strength, sensation, and function below the injured site. Some of the leading causes of SCI are accidental falls, motor vehicle accidents, trauma, sports, and recreational injuries, and diseases such as cancer, arthritis, osteoporosis, and ankylosing spondylitis. People with SCI can develop partial or complete paralysis and paraplegia.
This calls for the need for rehabilitation and assistive devices such as medical exoskeletons to stabilize and assist interlimb movements in patients with SCI at the T7-L5 and T -T6 levels. The increasing incidence of SCI is increasing the demand worldwide.
The launch of technologically advanced products is the key trend in the market. companies in the market are developing and launching advanced products with improved designs to reduce the weight and bulk of these devices. They plan to increase adjustability, improve durability, add one-handed controls, and make these devices more user-friendly.
Some of the technologically advanced products offered by suppliers include the next-generation Indego Therapy device for use in rehabilitation centers, launched by Parker-Hannifin in September 201, and the EksoNR, the next-generation EksoGT for use in neurorehabilitation, launched by Ekso. Bionics Holdings in August. 2019 etc. An increasing number of technologically advanced product launches are fueling the growth of the global market.
The lack of well-trained caregivers is the major challenge in the market. The application of medical exoskeletons in hospital settings, rehabilitation centers, or home care requires the assistance of highly efficient caregivers who can help move the exoskeleton. However, the availability of such dedicated caregivers to help patients with SCI and mobility impairments is limited.
Factors such as insufficient human resources, lack of standardization of training curricula and accreditation guidelines, and poor coordination between patients and caregivers during exoskeleton ambulation limit the availability of well-trained caregivers. Considering the above-mentioned factors, the lack of well-trained caregivers is hindering the growth of the global market.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
This report extensively covers market segmentation by mobility type (mobile and stationary exoskeleton), technology (powered and passive exoskeletons), and geography (North America, Europe, Asia, and Rest of World (ROW)). Medical exoskeletons are advanced assistive devices designed for individuals with Stroke, severe musculoskeletal injuries, and neurological disorders, including spinal cord injuries (SCIs), neuropathy, cerebral palsy, and multiple sclerosis. These self-assist exoskeletons enable users to stand and walk with crutches or a walker, providing balance and mobility. FDA regulations and ISO standards guide the development of these regulatory bodies-approved devices.
The market share growth of the mobile exoskeleton segment will be significant during the forecast period. Mobile exoskeletons are devices that can be used in home care to support knee or hip movement. These devices help patients with spinal cord injury (SCI) and mobility impairments to stand and walk with crutches or a walker to maintain balance. Mobile exoskeletons use a multi-level controller and sensor to determine and enable patient movement. In addition, these devices can be configured and customized according to individual needs.
Get a glance at the market contribution of various segments View the PDF Sample
The mobile exoskeleton segment was valued at USD 68.90 million in 2018. Patients with SCIs and traumatic brain injury using mobile exoskeletons. These products are available in a variety of configurations and can be adjusted to a wide range of leg lengths, hip widths, and foot sizes. In October 2022, a Stanford University research team funded by the National Institutes of Health (NIH) developed an exoskeleton that quickly adapts to the user during normal walking. The researchers developed a model to estimate relative metabolic rates from movement data. This allowed the exoskeleton to carry all the necessary information from portable sensors while walking, eliminating the need to collect data in the laboratory. Such customization and the assistance provided by such devices will fuel the growth of the market during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The United States is the largest contributor to the North American market due to advanced healthcare facilities, increased prevalence of physical injuries due to SCI, and high demand for self-supporting medical exoskeletons. In 2021, the incidence of SCI in the United States was 5 million. In addition to favorable policies regarding medical extraskeletal coverage and third-party commercial payer reimbursement, the American Spinal Injury Association (ASIA) aims to increase awareness of treatment options available to SCI patients and the availability of key providers. such as Exo Bionics Holdings and Parker-Hannifin Corp. (Parker-Hannifin), which provides medical exoskeletons in the region, is driving the market growth.
Segment Overview
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The market is experiencing significant growth due to the increasing demand for assistive devices that enhance mobility and improve the quality of life for individuals with various medical conditions. These devices, such as ReWalk, Ekso, and SuitX, are designed using advanced technologies like Regulatory bodies such as the FDA are actively supporting the development and adoption of these devices through approvals and reimbursement policies. The market for these devices is segmented based on applications, including Spinal Cord Injuries, Strokes, and Multiple Sclerosis. Assistive technologies like Focus and Evexatech are also playing crucial roles in the development of these devices. The market is expected to grow further due to the rising number of aging populations and the increasing incidence of neurological disorders. The use of robotics and biomimetic designs in exoskeletons is also driving innovation in the market.
Additionally, the market is witnessing significant advancements in rehabilitation approaches with the integration of innovative technologies like cloud computing, deep learning, and artificial intelligence. These technologies enhance the functionality of the rehabilitation device designed for both upper extremity and lower extremity support, catering to individuals with musculoskeletal disorders in the healthcare sector and beyond. Industries such as aircraft manufacturers, shipyards, and foundries are increasingly adopting industrial exoskeletons to improve workplace safety and prevent work-related accidents. With smart sensors and sophisticated control strategies, these exoskeletons offer enhanced neuroplasticity and efficiency, promising a significant return on investment for businesses investing in this form of exoskeleton technology.
Further, the medical exoskeleton market sees companies like B-Temia, Bioventus, and Hocoma pioneering innovative solutions for assistive ambulatory devices. These devices cater to individuals with motor impairments due to cardiovascular or metabolic disorders and are also utilized by able-bodied users in rehabilitation and home settings. With advancements in actuation technologies, exoskeletons find applications in various industries, including shipyards, foundries, aeronautics, and factory works, enhancing frontline workers' capabilities and improving overall safety and productivity.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
159 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 55.77% |
|
Market Growth 2024-2028 |
USD 2.87 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
38.93 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 41% |
|
Key countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Bionik Laboratories Corp., B Temia, Cyberdyne Inc., DIH Group, Ekso Bionics Holdings Inc., Exoatlet Global SA, Focal Meditech, GOGOA Mobility Robots SL, Honda Motor Co. Ltd., Marsi Bionics SL, MYOMO INC., Ottobock SE and Co. KGaA, P and S Mechanics Co. Ltd., Parker Hannifin Corp., Rehab Robotics Co. Ltd., ReWalk Robotics Ltd., Rex Bionics Ltd., Sarcos Technology and Robotics Corp., Wandercraft, and Wearable Robotics Srl |
|
Market dynamics |
Parent market analysis, Market forecast, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Mobility Type
7 Market Segmentation by Technology
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.